Kenneth Hegewald
Foot & Ankle Surgery · Portland, ORNPI 1427344563
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 49.4% of the total. Reporting peaked in 2019 at $3,170 and has fallen 93.6% since, to $203 in 2025.
Across 51 payments — averaging $210.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Steelhead Surgical Inc$3K
- Stryker$1K
- Paragon 28, Inc.$832
- Zimmer Biomet$111
- Next Science LLC$110
- plus $342 from 8 others
What the payments were for
- Speaking & faculty fees$4,00037%
- Travel & lodging$2,88727%
- Food & beverage$1,84717%
- Education$2,00519%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 13 | $5,303 |
| Steelhead Surgical Inc | 7 | $2,796 |
| Stryker(2 entities) | 10 | $1,246 |
| Paragon 28, Inc. | 6 | $832 |
| Zimmer Biomet | 1 | $111 |
| Next Science LLC | 1 | $110 |
| Treace Medical Concepts, Inc. | 3 | $78 |
| Fusion Orthopedics USA, LLC | 1 | $59 |
| Johnson & Johnson(2 entities) | 3 | $55 |
| DJO, LLC | 1 | $39 |
| Trilliant Surgical LLC. | 1 | $35 |
| Nalu Medical, Inc. | 1 | $31 |
| Smith+Nephew | 2 | $31 |
| Vericel Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,739 in reported general payments places this provider in the 85th percentile of 113 foot & ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $694 |
| Oxycodone Hcl | 75 | $323 |
| Cephalexin | 31 | $306 |
| Gabapentin | 34 | $258 |
| Celecoxib | 21 | $244 |
| Tramadol Hcl | 54 | $185 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $136 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Portland
- Natalie MesnierPortland$339K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Kevin DriscollPortland$21K
- John MassoudPortland$14K
- Steven LaxsonPortland$11K
- Lara AtwaterPortland$10K
- Denny lePortland$9K
- Andrew HuPortland$7K
- Paul JonesPortland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.